Leadership

Stephanie Staras, Ph.D., will co-lead the program with Dejana Braithwaite, Ph.D.

Zhijian Qian, Ph.D., will co-lead the program with Lizi Qu, Ph.D.

Ramzi Salloum, Ph.D., will be responsible for overseeing the center-wide effort to reduce the burden of cancer.

The committee guides and implements activities to disseminate best practices across AACI cancer center clinical trials offices.

Thomas George, M.D., FACP, becomes deputy director and Paul Crispen, M.D., becomes associate director for clinical research.

John R. Wingard, M.D., retires after 27 years at the University of Florida and made an immeasurable impact on patients, faculty and trainees.

Jonathan D. Licht, M.D., spoke with the Cancer Letter about achieving NCI designation.

Ji-Hyun Lee, DrPH, will serve as ASA president-elect starting Jan. 1, 2024, with her term as president beginning Jan. 1, 2025.

Thomas George, M.D., FACP, and Merry Jennifer Markham, M.D., FACP, FASCO, were honored for exemplifying cancer care advocacy in 2022.

Ji-Hyun Lee, DrPH, director of the division of quantitative sciences at the Cancer Center, is one of two candidates for ASA president.